PCSK9 and hyperlipidemia: Injecting WT C57BL/6 mice with a low dose of AAV8-PCSK9 increased both serum PCSK9 and cholesterol levels only in male mice, whereas 3 times the original dose of AAV8-PCSK9 was required to induce hyperlipidemia in the female mice (35).